ArticleEndoscopy international open2026
Durable endoscopic gastrojejunal anastomosis using the double-lumen apposing metal stent septotomy technique: Feasibility study.
Article in Endoscopy international open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on "Durable endoscopic gastrojejunal anastomosis using the double-lumen apposing metal stent septotomy technique: Feasibility study".Endoscopy international open · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and study aims: Surgical gastrojejunostomy (S-GJ) is standard treatment for gastric outlet obstruction (GOO), but is associated with significant morbidity, high cost, and prolonged recovery. Endoscopic ultrasound-guided gastroenterostomy (EUS-GE) provides a minimally invasive alternative; however, the anastomosis often closes after removal of the lumen-apposing metal stent (LAMS), limiting its role to palliation. We evaluated feasibility of the double LAMS septotomy technique to achieve durable gastroenterostomy without reliance on indwelling stents. Patients and methods: This was a multicenter pilot-feasibility study in which consecutive adults with GOO underwent EUS-GE with double LAMS septotomy between 2024 and 2025. Step one involved placement of two adjacent LAMS to create parallel gastroenteric fistulas. Step two, performed 3 months later, included stent removal with or without septotomy to consolidate the anastomosis. Technical success, clinical success, adverse events (AEs), and sustained patency of the anastomosis after LAMS removal were assessed prospectively. Results: Six patients (Mean age 70.3 years, 50% benign GOO) underwent the procedure. Technical and clinical success rates were 100%. Four patients completed both steps, with sustained anastomotic patency confirmed endoscopically or radiographically. Among these, spontaneous septum necrosis occurred in two patients (50%) and two patients (50%) required septotomy. Nutritional status improved (mean albumin +0.75 g/dL). There were no major AEs. The patients had no recurrence of symptoms after a mean follow up 26.2 weeks and 17.8 weeks after step one and step two, respectively. Conclusions: The double LAMS septotomy technique is technically feasible, safe, and achieves durable gastrojejunostomy. This strategy may broaden the therapeutic role of EUS-GE in benign disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.